Nericid C Cream
Topical corticoid cream with antimicrobial additive Composition:
1g Nericid C cream contains : 1 mg ( 0.1 %) diflucortolone valerate and
10 mg (1%) Chlorquinaldol .
Properties:
Diflucortolone valerate suppresses inflammation in inflammatory and
allergic skin conditions and alleviates the subjective complaints such as
itching, burning and pain.
Chlorquinaldol inhibits the growth of bacteria, yeasts, dermatophytes and
moulds. Indications & usage :
Initial intermittent treatment of bacterially and /or mycotically infected skin
diseases as long as inflammatory concomitant symptoms predominate and in
which a cream is indicated. These include:
- Eczemas with bacterial and/or mycotic superimposition, such as nummular,
seborrhoeic and dyshidrotic eczema; eczema in varicose syndrome ( but not
applied directly onto lower limb ulcers) ; bacterid , eczematid.
- Skin infections, such as pyoderma (folliculitis, impetigo)and erythrasma.
- Dermatomycoses (tinea, candidiasis, pityriasis versicolor).
- Nericid C is also used to prevent the above mentioned bacterial and
fungal infections in inflammatory and allergic skin diseases. Contra - indications :
- Tuberculous or syphilitic processes in the area to be treated ; virus diseases
( e.g. vaccinia, chickenpox, shingles).
- As a general rule, topical preparations containing corticoids should not be
applied during the first trimester of pregnancy.
Application to large areas of the body or for prolonged periods, must be
avoided . Side effects :
-The following reactions may occur when Nericid C is applied to large areas
of the body (about 10% and more ) and/or for long periods of time (more
than 4 weeks): local concomitant symptoms such as atrophy of the skin,
telangiectasia striae, acneform changes of the skin, perioral dermatitis,
increased growth of body hair (hypertrichosis) and systemic effects of the
corticoid due to absorption, In rare cases allergic skin reactions may occur.
-Side effects cannot be excluded in neonates whose mothers have been
treated extensively or for a prolonged period of time during pregnancy or
during lactation ( for example, reduced adrenocortical function, when
applied during the last weeks of pregnancy). Warnings & precautions :
Nericid C should not be allowed to come into contact with the eyes when
being applied to the face .
If roseola or perioral dermatitis is present, Nericid C must not be applied
to the face. Dosage & administration:
Unless otherwise prescribed by the physician at the beginning of treatment
Nericid C is applied thinly twice or , perhaps three times per day. Once the
clinical picture has improved, one application per day is usually sufficient.
Babies and children up to the age of 4 years should not be treated with
Nericid C for longer than three weeks, particularly on skin areas covered
by nappies,
If the skin dries out too much under protracted use of Nericid C a neutral
fatty preparation (e.g. Nericid Ointment or Fatty Ointment) is to be
applied additionally or alternately . Packing :
Tube of l0 g . Storage :
Store at a temperature not exceeding 25 oc . | 
